Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2354)
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
19,954
Price
$81.31
Total Value
$1.62M
Shares Held After
383,803
% of Holdings
4.9%
HENRY SCHEIN INC (HSIC)
BERGMAN STANLEY M — Director
Shares
23,858
Price
$81.31
Total Value
$1.94M
Shares Held After
403,757
% of Holdings
5.6%
IDEAYA Biosciences, Inc. (IDYA)
Stein Jeffrey — Director
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%
ENSIGN GROUP, INC (ENSG)
SMITH BARRY M — Director
Shares
700
Price
$213.02
Total Value
$149.11K
Shares Held After
22,852
% of Holdings
3.0%
InfuSystem Holdings, Inc (INFU)
Steele Barry G — Executive VP and CFO
Shares
2,064
Price
$9.16
Total Value
$18.91K
Shares Held After
88,000
% of Holdings
2.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Wambeke David J. — Chief Business Officer
Shares
1,000,000
Price
$0.67
Total Value
$670.40K
Shares Held After
1,000,000
% of Holdings
100.0%
Showing 2051–2100 of 2354 transactions (page 42 of 48)